Drugs / GW813893
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00541320 | Feb 2007 → ? | venous thromboembolism | GlaxoSmithKline | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW813893 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00541320 ↗ |
| Modality | Small molecule | — CHEMBL220050 ↗ |